Skip to main content
. 2017 Mar 27;37(2):BSR20160544. doi: 10.1042/BSR20160544

Figure 2. Comparisons of bone metabolism parameters of patients with T2DN among three groups.

Figure 2

Note: *P<0.05 compared with the VD group; #P<0.05 compared with the PIO group; &P<0.05 compared with the severe group; $P<0.05 compared with the moderate group; VD + PIO, vitamin D plus pioglitazone hydrochloride.